NCPC(SH:600812) Zheng Quan Zhi Xing·2025-06-11 12:23Core Viewpoint - The legal opinion from Beijing Deheng Law Firm confirms that the 2024 Annual General Meeting of Huabei Pharmaceutical Co., Ltd. was convened and conducted in compliance with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [2][15]. Group 1: Meeting Procedures - The meeting is scheduled for June 11, 2025, and the notice was announced more than 20 days prior to the meeting date, complying with legal requirements [2][4]. - The actual time and location of the meeting matched the details provided in the notice, confirming adherence to the announced procedures [5][6]. Group 2: Attendance and Voting - A total of 569 attendees participated in the meeting, representing 996,253,660 shares with voting rights, which is a significant portion of the total [6][7]. - The voting results showed a high level of agreement on the proposals, with the majority of votes in favor, indicating strong shareholder support [9][10][12]. Group 3: Legal Compliance - The legal opinion asserts that the meeting's convening, attendance, proposal procedures, and voting processes were all in accordance with the Company Law, Securities Law, and the company's articles of association [3][15]. - The results of the voting were properly documented and disclosed, ensuring transparency and compliance with regulatory standards [8][13].